These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14425244)

  • 1. [Lucofene- a new anorexigenic drug for the treatment of obesity].
    MUNE O; ENGBERG PALLESEN A
    Ugeskr Laeger; 1960 May; 122():605-11. PubMed ID: 14425244
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of appetite-suppressant drugs for weight reduction without dieting.
    FISH CH
    Clin Med (Northfield); 1962 Feb; 69():427-30. PubMed ID: 15445746
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of amphetamine as an appetite depressant.
    GALLAGHER NI; KNIGHT WA
    J Chronic Dis; 1958 Aug; 8(2):244-52. PubMed ID: 13563605
    [No Abstract]   [Full Text] [Related]  

  • 4. Value of ephedrine-ethlenediamine as an appetite depressant: comparison with d-amphetamine sulfate.
    KUPERSMITH IH
    Curr Ther Res Clin Exp; 1960 Feb; 2():39-42. PubMed ID: 14412826
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of anorexigenic drugs in the treatment of the resistant obese patient.
    KROGER WS
    Psychosomatics; 1962; 3():454-7. PubMed ID: 14035909
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of appetite suppressants.
    CASS LJ
    Ann Intern Med; 1959 Dec; 51():1295-302. PubMed ID: 13808189
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anorexigenic action of diethylpropion. Preliminary study].
    GARCIA DE LOS RIOS M; BAHAMONDES G; VALIENTE S; VALLEJOS J; CANESSA I
    Rev Med Chil; 1961 Aug; 89():595-7. PubMed ID: 13896789
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychologic factors in obesity and anorexic drugs.
    KROGER WS
    Am Pract Dig Treat; 1959 Dec; 10():2169-71. PubMed ID: 14412107
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of the effectiveness of certain anorexigenic agents.
    FAZEKAS JF; EHRMANTRAUT WR; KLEH J
    Am J Med Sci; 1958 Dec; 236(6):692-9. PubMed ID: 13606123
    [No Abstract]   [Full Text] [Related]  

  • 10. USE OF AN AMPHETAMINE-COMBINATION DRUG IN AN ANTI-OBESITY CLINIC.
    BERMAN MI; ANDERSON IR
    Md State Med J; 1965 Jan; 14():29-31. PubMed ID: 14233312
    [No Abstract]   [Full Text] [Related]  

  • 11. [ON THE DRUG THERAPY OF OBESITY].
    NEUBERT D
    Z Arztl Fortbild (Berl); 1965 Feb; 54():134-46. PubMed ID: 14266804
    [No Abstract]   [Full Text] [Related]  

  • 12. A clinical pharmacologic study of benzphetamine (didrex), a new appetite suppressant.
    OSTER HL; MEDLAR RE
    Ariz Med; 1960 Jul; 17():398-404. PubMed ID: 14429287
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mode of action and indication for appetite depressants in the treatment of obesity].
    Stauffacher W
    Schweiz Med Wochenschr; 1975 Apr; 105(15):461-6. PubMed ID: 1124373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A COMPARISON OF THE APPETITE SUPPRESSING PROPERTIES OF DEXAMPHETAMINE AND PHENTERMINE.
    SEATON DA; ROSE K; DUNCAN LJ
    Scott Med J; 1964 Nov; 9():482-5. PubMed ID: 14231545
    [No Abstract]   [Full Text] [Related]  

  • 15. THE USES AND ABUSES OF APPETITE SUPPRESSANTS.
    SEATON DA; DUNCAN LJ
    Br J Clin Pract; 1965 Feb; 19():89-93. PubMed ID: 14258387
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind study of an anorexigenic combination.
    ROSENBERG BA
    Curr Ther Res Clin Exp; 1961 Feb; 3():45-50. PubMed ID: 13743379
    [No Abstract]   [Full Text] [Related]  

  • 17. The anorexigenic effect of sustained-release dexedrine preparations.
    GELVIN EP; McGAVACK TH; KENIGSBERG S
    Am J Dig Dis; 1953 Oct; 20(10):307-12. PubMed ID: 13092091
    [No Abstract]   [Full Text] [Related]  

  • 18. MANAGEMENT OF THE OBESE PATIENT: A REVIEW OF ADJUNCTIVE MEASURES.
    EHRMANTRAUT WR; SAVARESE CJ
    J Am Med Womens Assoc; 1964 Sep; 19():750-4. PubMed ID: 14173959
    [No Abstract]   [Full Text] [Related]  

  • 19. Benzphetamine in the management of obesity-controlled studies.
    PAVER RL
    Rocky Mt Med J; 1963 Feb; 60():37-9. PubMed ID: 13942074
    [No Abstract]   [Full Text] [Related]  

  • 20. SUSTAINED-ACTION AMPHETAMINE-MEPROBAMATE COMBINATION FOR THE TREATMENT OF OBESITY.
    BATTERMAN RC
    Curr Ther Res Clin Exp; 1964 Jul; 6():447-53. PubMed ID: 14203275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.